Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 327
Selected: 0
NCT IDTitle
NCT00580983Optimized Intensity Modulated Irradiation for Head and Neck Cancer
NCT02463994A Pilot Study of MPDL3280A and HIGRT in Metastatic NSCLC
NCT04574856Multiparametric MR-Guided High Dose Adaptive Radiotherapy With Concurrent Temozolomide in Patients With Newly Diagnosed Glioblastoma
NCT06046014Feasibility of Expressive Writing for Body Image Distress and Anxiety Among Adolescent and Young Adult Cancer Survivors
NCT01389076Trial of Low-Dose Methotrexate and I 131 Tositumomab for Previously Untreated, Advanced-Stage, Follicular Lymphoma
NCT04552418Intestinal Microbiome Modification With Resistant Starch in Patients Treated With Dual Immune Checkpoint Inhibitors
NCT07532525Pomalidomide After CAR T-cell Therapy for the Treatment of Relapsed or Refractory CD19+ B-cell Leukemia or Lymphoma
NCT00955188Computer-Based Tailored or Standard Information for Colorectal Cancer Screening
NCT00148122A Study of a New Combination and Schedule of Chemotherapy Drugs for the Treatment of Head and Neck Cancer
NCT00726375The Use of Etanercept Enbrel as Sole Treatment for Grade I Acute Graft Versus Host Disease
NCT05583422Evaluating a Pharmacogenetic Testing Panel in Patients Suspected to be at Increased Risk for Pharmacogenetics-related AEs While Receiving Fluoropyrimidine or Irinotecan Therapy
NCT00141739Study of Etanercept for the Prevention of Complications Resulting From Hematopoietic Stem Cell Transplantation (HSCT)
NCT04140162Phase 2 Study With Minimal Residual Disease (MRD) Driven Adaptive Strategy in Treatment for Newly Diagnosed Multiple Myeloma (MM) With Upfront Daratumumab-based Therapy
NCT04431635Dose De-escalation Study of the PI3k Alpha/Delta Inhibitor, Copanlisib Given in Combination With the Immunotherapeutic Agents, Nivolumab and Rituximab in Patients With Relapsed/Refractory Indolent Lymphoma
NCT01902745Fatigue Reduction Diet
NCT05901519A Pilot Study of Liver Protection Using Prednisone for Patients Receiving Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma
NCT03416153Individualized Adaptive De-escalated Radiotherapy for HPV-related Oropharynx Cancer
NCT00239200Lapatinib (GW572016) for Metastatic or Recurrent Squamous Cell Carcinoma Esophagus
NCT03287063Study Using Genomic, Histologic and Radiomic Analysis to Evaluate Regional Tumor Heterogeneity in Patients Undergoing Surgery for Newly Diagnosed Glioblastoma
NCT02277457Personalized Adaptive Radiation Therapy With Individualized Systemic Targeted Therapy (PARTIST) for Locally Advanced, Non-small Cell Lung Cancer With Genomic Driver Mutations
NCT00143871Study of Rituximab Plus High-Dose Chemotherapy Non-Hodgkin's Lymphoma
NCT03208712Radium-223 and Atezolizumab in Patients With Urothelial Carcinoma With Bone Metastases Who Have Had Disease Progression After Platinum-Based Chemotherapy
NCT05866302Parametric Response Mapping (PRM) for the Detection of Chronic Lung Injury in Hematopoietic Cell Transplant Recipients
NCT01029054Carfilzomib and Lenalidomide With Dexamethasone Combination in Newly Diagnosed, Previously Untreated Multiple Myeloma
NCT02118636Observational Study to Evaluate Mechanisms of Aromatase Inhibitor Associated Musculoskeletal Symptoms
NCT01750567A Pilot Study of Metformin Therapy in Patients With Relapsed Chronic Lymphocytic Leukemia (CLL) and Untreated CLL
NCT06234748Trial of Individualized Adaptive RT in HPV-related High Risk Oropharynx Cancer
NCT00637390A Phase I Study of Alemtuzumab in Patients With Relapsed Ovarian/Primary Peritoneal Cancer.
NCT00904345Study of Radiation (RT) Concurrent With Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcinoma (SCC)
NCT00399321A Pilot Study of Bone Mineral Density in Postmenopausal Women After Treatment for Breast Cancer
NCT04477200Mycophenolate Mofetil Combined With Radiation Therapy in Glioblastoma
NCT01666899Effect of Radiation on Tissue for Delayed Breast Reconstruction
NCT06784336Phase II Study of Resistant Potato Starch Plus Deferasirox to Improve Outcomes in Patients Undergoing Allogeneic Stem Cell Transplantation
NCT03601819Pacritinib in Relapsed/Refractory Lymphoproliferative Disorders
NCT02097732Ipilimumab Induction in Patients With Melanoma Brain Metastases Receiving Stereotactic Radiosurgery
NCT03121287Early Imaging Biomarkers in NSCLC
NCT03763838Acupressure for Fatigue in Ovarian Cancer Survivors
NCT04497038Cabozantinib in Patients With Advanced Hepatocellular Carcinoma With Child Pugh Class B Cirrhosis After First-Line Therapy
NCT02013453A Phase II Trial of Proton Pump Inhibitors With Chemotherapy in Patients With Metastatic Head and Neck Cancer
NCT02338115Defining an Exposure Target for Weekly Paclitaxel Infusion in Breast Cancer Patients
NCT00763490Trial Of Double Umbilical Cord Blood Transplantation
NCT07094685Ivonescimab Before Surgery for the Treatment of Resectable Stage II-IV Head and Neck Cancer
NCT05140252Avoiding Low-value Treatments in Older Women With Early-stage Breast Cancer: Piloting a Patient Decision Aid
NCT01661114A Trial of Gemcitabine, Infusional 5-Fluorouracil and Cisplatin for Advanced Pancreatic and Biliary Cancers
NCT04925089Localized Leiomyosarcoma Biomarker Protocol
NCT04051047Gemcitabine in Newly-Diagnosed Diffuse Midline Glioma
NCT05965180Interstitial Assessment of Architectural Heterogeneity in Prostate Cancer Using a Fine Needle Photoacoustic Probe
NCT00176787Radiation Therapy With Capecitabine in Rectal Cancer
NCT00644683A Pilot Observational Study to Assess Changes in Biochemical Parameters of Ovarian Reserve With Chemotherapy
NCT07121595Personalized Neck Radiation Therapy Directed by Sentinel Lymph Node Biopsy for the Treatment of Oral Cavity Squamous Cell Carcinoma, PRECEDENT Trial